Related Experiment Video
Updated: Aug 26, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional
L V Ronco1, A Y Karpova, M Vidal
1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 USA.
Abstract:
Interferon regulatory factor-3 (IRF-3) was found to specifically interact with HPV16 E6 in a yeast two-hybrid screen. IRF-3 is activated by the presence of double-stranded RNA or by virus infection to form a stable complex with other transcriptional regulators that bind to the regulatory elements of the IFNbeta promoter. We show that IRF-3 is a potent transcriptional activator and demonstrate that HPV16 E6 can inhibit its transactivation function. The expression of HPV16 E6 in primary human keratinocytes inhibits the induction of IFNbeta mRNA following Sendai virus infection. The binding of HPV16 E6 to IRF-3 does not result in its ubiquitination or degradation. We propose that the interaction of E6 with IRF-3 and the inhibition of IRF-3's transcriptional activity may provide the virus a means to circumvent the normal antiviral response of an HPV16-infected cell.
Insights
Human papillomavirus type 16 E6 protein inhibits interferon regulatory factor-3 (IRF-3) activation. This interaction may help HPV16 evade the host
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Interferon regulatory factor-3 (IRF-3) is a key transcription factor in the innate immune response.
- IRF-3 activation is crucial for antiviral defense, particularly against RNA viruses.
- Human papillomavirus type 16 (HPV16) is a common oncogenic virus.
Purpose of the Study:
- To investigate the interaction between HPV16 E6 and IRF-3.
- To determine the functional consequences of this interaction on IRF-3 activity and antiviral response.
Main Methods:
- Yeast two-hybrid screening to identify protein interactions.
- Reporter assays to assess transcriptional activation.
- Analysis of IFNbeta mRNA induction in primary human keratinocytes.
Main Results:
- HPV16 E6 specifically interacts with IRF-3.
- HPV16 E6 inhibits the transactivation function of IRF-3.
- HPV16 E6 expression in keratinocytes suppresses Sendai virus-induced IFNbeta mRNA production.
- The interaction does not lead to IRF-3 ubiquitination or degradation.
Conclusions:
- HPV16 E6 antagonizes the antiviral activity of IRF-3.
- This inhibition likely contributes to HPV16's immune evasion strategy in infected cells.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Abnormal Proliferation
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

